What is the treatment for Catheter-Related Bloodstream Infection (CRBSI) due to Enterobacter (E.) cloacae?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Catheter-Related Bloodstream Infection (CRBSI) due to Enterobacter cloacae

For CRBSI due to Enterobacter cloacae, remove the catheter immediately (short-term catheters) or promptly (long-term catheters), initiate empirical IV therapy with a fourth-generation cephalosporin, carbapenem, or β-lactam/β-lactamase combination based on local susceptibility patterns, and treat for 7-14 days after catheter removal if uncomplicated. 1

Catheter Management

Catheter removal is mandatory for successful treatment:

  • Short-term catheters: Remove immediately upon diagnosis of gram-negative CRBSI 1
  • Long-term catheters: Remove promptly, especially if severe sepsis, persistent bacteremia >72 hours despite appropriate therapy, or suppurative thrombophlebitis is present 1
  • Catheter salvage should NOT be attempted for E. cloacae CRBSI, as gram-negative bacilli require catheter removal for cure 1

Empirical Antibiotic Selection

Choose empirical therapy based on local antibiogram and severity of illness:

  • Fourth-generation cephalosporin (e.g., cefepime) 1
  • Carbapenem (e.g., meropenem, imipenem) 1
  • β-lactam/β-lactamase combination (e.g., piperacillin-tazobactam) 1
  • With or without an aminoglycoside for critically ill or septic patients 1

For critically ill patients, neutropenic patients, or those with known MDR colonization: Use combination therapy with two different classes of gram-negative agents until susceptibilities return, then de-escalate 1

Definitive Therapy

Once susceptibilities are available:

  • De-escalate to the narrowest-spectrum agent with activity against E. cloacae 1
  • E. cloacae typically produces AmpC β-lactamases, making third-generation cephalosporins unreliable 2
  • Preferred agents include fourth-generation cephalosporins (if susceptible), carbapenems, or fluoroquinolones based on susceptibility testing 1

Treatment Duration

Standard duration depends on clinical response:

  • 7-14 days for uncomplicated CRBSI after catheter removal 1
  • 4-6 weeks if persistent bacteremia >72 hours after catheter removal, endocarditis, or suppurative thrombophlebitis develops 1
  • 6-8 weeks if osteomyelitis is present 1

Monitoring and Follow-up

Obtain follow-up blood cultures:

  • Draw cultures 72 hours after initiating appropriate therapy 1
  • If cultures remain positive at 72 hours, remove any retained catheter and evaluate for endovascular infection or metastatic complications 1
  • Perform transesophageal echocardiography if bacteremia persists >72 hours or signs of endocarditis develop 1

Critical Pitfalls to Avoid

Do not use third-generation cephalosporins as definitive therapy: E. cloacae produces inducible AmpC β-lactamases that confer resistance to third-generation cephalosporins even when initial susceptibility testing suggests susceptibility 2

Do not attempt catheter salvage: Unlike coagulase-negative staphylococci, gram-negative CRBSI requires catheter removal for cure 1

Do not use oral antibiotics: Active CRBSI requires intravenous therapy due to the severity of infection and need for high serum antibiotic concentrations 3

Do not delay catheter removal in septic patients: Antibiotic therapy alone without catheter removal results in 5-fold higher treatment failure rates 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Klebsiella CRBSI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.